Rankings
▼
Calendar
LXRX
Lexicon Pharmaceuticals, Inc.
$729M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$20M
Gross Profit
-$28M
-140.0% margin
Operating Income
-$37M
-184.3% margin
Net Income
-$38M
-189.7% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
+60.8%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$48M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$558M
Total Liabilities
$341M
Stockholders' Equity
$217M
Cash & Equivalents
$38M
← FY 2016
All Quarters
Q3 2016 →
LXRX Q2 2016 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
